Your browser doesn't support javascript.
loading
p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration.
González-Terán, Bárbara; Matesanz, Nuria; Nikolic, Ivana; Verdugo, María Angeles; Sreeramkumar, Vinatha; Hernández-Cosido, Lourdes; Mora, Alfonso; Crainiciuc, Georgiana; Sáiz, María Laura; Bernardo, Edgar; Leiva-Vega, Luis; Rodríguez, Elena; Bondía, Victor; Torres, Jorge L; Perez-Sieira, Sonia; Ortega, Luis; Cuenda, Ana; Sanchez-Madrid, Francisco; Nogueiras, Rubén; Hidalgo, Andrés; Marcos, Miguel; Sabio, Guadalupe.
Afiliação
  • González-Terán B; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Matesanz N; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Nikolic I; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Verdugo MA; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Sreeramkumar V; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Hernández-Cosido L; Bariatric Surgery Unit, Department of General Surgery, University Hospital of Salamanca, Salamanca, Spain Department of Surgery, University of Salamanca, Salamanca, Spain.
  • Mora A; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Crainiciuc G; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Sáiz ML; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Bernardo E; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Leiva-Vega L; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Rodríguez E; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Bondía V; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Torres JL; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, Salamanca, Spain Department of Medicine, University of Salamanca, Salamanca, Spain.
  • Perez-Sieira S; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Ortega L; Bariatric Surgery Unit, Department of General Surgery, University Hospital of Salamanca, Salamanca, Spain Department of Surgery, University of Salamanca, Salamanca, Spain.
  • Cuenda A; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Sanchez-Madrid F; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Nogueiras R; Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.
  • Hidalgo A; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
  • Marcos M; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, Salamanca, Spain Department of Medicine, University of Salamanca, Salamanca, Spain.
  • Sabio G; Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain guadalupe.sabio@cnic.es.
EMBO J ; 35(5): 536-52, 2016 Mar 01.
Article em En | MEDLINE | ID: mdl-26843485
Non-alcoholic fatty liver disease (NAFLD) is a major health problem and the main cause of liver disease in Western countries. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood. The disease begins with an excessive accumulation of triglycerides in the liver, which stimulates an inflammatory response. Alternative p38 mitogen-activated kinases (p38γ and p38δ) have been shown to contribute to inflammation in different diseases. Here we demonstrate that p38δ is elevated in livers of obese patients with NAFLD and that mice lacking p38γ/δ in myeloid cells are resistant to diet-induced fatty liver, hepatic triglyceride accumulation and glucose intolerance. This protective effect is due to defective migration of p38γ/δ-deficient neutrophils to the damaged liver. We further show that neutrophil infiltration in wild-type mice contributes to steatosis development by means of inflammation and liver metabolic changes. Therefore, p38γ and p38δ in myeloid cells provide a potential target for NAFLD therapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infiltração de Neutrófilos / Proteína Quinase 12 Ativada por Mitógeno / Proteína Quinase 13 Ativada por Mitógeno / Hepatopatia Gordurosa não Alcoólica / Fígado / Obesidade Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: EMBO J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infiltração de Neutrófilos / Proteína Quinase 12 Ativada por Mitógeno / Proteína Quinase 13 Ativada por Mitógeno / Hepatopatia Gordurosa não Alcoólica / Fígado / Obesidade Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: EMBO J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha